ABSTRACT
Non-Hispanic black (NHB) women are more likely to experience an endometrial carcinoma (EC) recurrence compared to non-Hispanic white (NHW) women. The extent to which tumor characteristics, socioeconomic status (SES) and treatment contribute to this observation is not well defined. In the NRG Oncology/Gynecology Oncology Group (GOG) 210 Study we evaluated associations between race/ethnicity and EC recurrence according to tumor characteristics with adjustment for potential confounders. Our analysis included 3,199 NHW, 532 NHB and 232 Hispanic women with EC. Recurrence was documented during follow-up. We used Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between race/ethnicity and EC recurrence in models stratified by histologic subtype (low-grade endometrioid, high-grade endometrioid, serous, mixed cell, carcinosarcoma, clear cell) or stage (I, II, III) and adjusted for age, SES, body mass index, smoking status and treatment. In histologic subtype-stratified models, higher EC recurrence was noted in NHB women with low-grade endometrioid (HR = 1.94, 95% CI = 1.21-3.10) or carcinosarcomas (HR = 1.66, 95% CI = 0.99-2.79) compared to NHWs. In stage-stratified models, higher EC recurrence was noted among NHB women with stage I (HR = 1.48, 95% CI = 1.06-2.05) and Hispanic women with stage III disease (HR = 1.81, 95% CI = 1.11-2.95). Our observations of higher EC recurrence risk among NHB and Hispanic women, as compared to NHW women, were not explained by tumor characteristics, SES, treatment or other confounders. Other factors, such as racial differences in tumor biology or other patient factors, should be explored as contributors to racial disparities in EC recurrence.
Subject(s)
Carcinoma, Endometrioid/ethnology , Carcinosarcoma/ethnology , Endometrial Neoplasms/ethnology , Ethnicity/statistics & numerical data , Neoplasm Recurrence, Local/ethnology , Aged , Carcinoma, Endometrioid/pathology , Carcinoma, Endometrioid/therapy , Carcinosarcoma/pathology , Carcinosarcoma/therapy , Endometrial Neoplasms/pathology , Endometrial Neoplasms/therapy , Female , Follow-Up Studies , Health Status Disparities , Humans , Middle Aged , Neoplasm Recurrence, Local/therapy , Neoplasm Staging , Proportional Hazards Models , Prospective Studies , Social Class , Treatment OutcomeABSTRACT
The International Gynocologic Cancer Society is a biannual meeting for those multidiscipline physicians who are involved in research and the clinical care of women with a gynecologic cancer. Approximately 3000 physicians from all geographic areas attended and heard presentations covering all aspects of gynecologic cancer.
